Infections in patients with multiple myeloma in the era of high-dose therapy and novel agents.

@article{Nucci2009InfectionsIP,
  title={Infections in patients with multiple myeloma in the era of high-dose therapy and novel agents.},
  author={Marcio Nucci and Elias Anaissie},
  journal={Clinical infectious diseases : an official publication of the Infectious Diseases Society of America},
  year={2009},
  volume={49 8},
  pages={1211-25}
}
The introduction of stem cell transplantation and the novel anti-myeloma agents, bortezomib, thalidomide, and lenalidomide, have improved the outcome of patients with multiple myeloma. These advances have transformed myeloma into a chronic condition, with multiple relapses and salvage therapies, all of which result in cumulative immunosuppression and higher risk of infection. In addition to the immunodeficiency related to myeloma and its complications, the type of anti-myeloma therapy used also… CONTINUE READING
71 Citations
125 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 71 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 125 references

Similar Papers

Loading similar papers…